Search results
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 5 days agoThe decline appears to be the result of investors taking profits after Moderna stock soared 25% last...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 1 day agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 4 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 5 days agoModerna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via Yahoo News· 6 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 6 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 6 days agoThe stock’s drop comes as Moderna awaits important developments involving its experimental cancer...
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 5 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 4 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...